Biomarin Pharmaceutical Inc
F:BM8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biomarin Pharmaceutical Inc
F:BM8
|
US |
|
O
|
Olin Corp
SWB:OLN
|
US |
|
Aviva PLC
F:GU8
|
UK |
|
A
|
Aflac Inc
F:AFL
|
US |
|
E
|
Eni SpA
F:ENI
|
IT |
|
M
|
ManpowerGroup Inc
XMUN:MPW
|
US |
|
W
|
Whitehaven Coal Ltd
F:WC2
|
AU |
|
3
|
3M Co
XMUN:MMM
|
US |
|
Lundin Mining Corp
TSX:LUN
|
CA |
|
J
|
Jones Lang LaSalle Inc
F:4J2
|
US |
|
A
|
Abbott Laboratories
F:ABL
|
US |
|
T
|
Teck Resources Ltd
F:TEKB
|
CA |
|
F
|
Fluor Corp
BMV:FLR
|
US |
|
L
|
Lamar Advertising Co
F:6LA
|
US |
|
L
|
Lundin Mining Corp
XMUN:GXD
|
CA |
|
C
|
Copart Inc
SWB:CO6
|
US |
|
N
|
Novartis AG
XMUN:NOT
|
CH |
|
B
|
Banco Bilbao Vizcaya Argentaria SA
BMV:BBVA
|
ES |
|
S
|
Standard Chartered PLC
XBER:STD
|
UK |
|
TAL Education Group
LSE:0A2X
|
CN |
|
Saipem SpA
F:SPE1
|
IT |
Wall St Price Targets
BM8 Price Targets Summary
Biomarin Pharmaceutical Inc
According to Wall Street analysts, the average 1-year price target for BM8 is 71.09 EUR with a low forecast of 39.36 EUR and a high forecast of 98.21 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BM8's stock price target?
Price Target
71.09
EUR
According to Wall Street analysts, the average 1-year price target for BM8 is 71.09 EUR with a low forecast of 39.36 EUR and a high forecast of 98.21 EUR.
What is the Revenue forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 8 years is 8%.
What is the Gross Profit forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 8 years is 8%.
What is the Operating Income forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
14%
The compound annual growth rate for Operating Income over the next 8 years is 14%.
What is the Pre-Tax Income forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
51%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 51%.
What is the Net Income forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
24%
The compound annual growth rate for Net Income over the next 8 years is 24%.
